中国科学技术大学傅斌清--中文主页-- Binqing Fu, Xiaoling Xu, Haiming Wei. Why tocilizumab could be an effective treatment for severe COVID 19? Journal of translational medicine, (2020) Apr 14; 18(1):164.

Binqing Fu, Xiaoling Xu, Haiming Wei. Why tocilizumab could be an effective treatment for severe COVID 19? Journal of translational medicine, (2020) Apr 14; 18(1):164.

发布时间：2021-07-10点击次数：

是否译文：否

发表时间： 2021-09-03

上一条：Zhou YG#, Fu BQ#, Zheng XH#, Wang DS, Zhao CC, Qi YJ, Sun R, Tian ZG, Xu XL, Wei HM: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. National Science Review, 2020, nwaa041, doi.org/10.1093/nsr/nwaa041 下一条：Subsets of human natural killer cells and their regulatory effects